Trends in prevalence and outcomes of acute coronary syndrome associated with cocaine consumption: The RUTI-cocaine study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 23 08 2018
revised: 08 11 2018
accepted: 06 12 2018
pubmed: 1 1 2019
medline: 24 12 2019
entrez: 1 1 2019
Statut: ppublish

Résumé

The use of cocaine as a recreational drug has increased over recent years. In this study, we aimed to analyze the prevalence, and in-hospital and long-term outcomes of acute coronary syndrome (ACS) associated with cocaine consumption (ACS-ACC). A prospective observational registry of young patients hospitalised with ACS from 2001 through 2015, we analysed ACS-ACC temporal trends, clinical characteristics, and major adverse cardiovascular events (MACE) during long-term follow-up. There were 8153 admissions with ACS, of whom 864 patients were ≤50-years-old; 59 patients (6.8%) presented with ACS-ACC. The prevalence of patients with a history of cocaine consumption increased to maximum of 18% in 2008 with no variations thereafter (r = 0.74, p < 0.001). The ACS-ACC incidence increased over time from 5% to 9% (r = 0.25, p = 0.07). Compared to patients with ACS not associated with cocaine consumption, the ACS-ACC exhibited a higher incidence of in-hospital ventricular tachycardia (16.9% vs 4.7%, p < 0.001) and trends to in-hospital mortality (3.4% vs 1.0%, p = 0.097); during a median follow-up of 5.6 years, ACS-ACC had higher risk of MACE (HR 1.83; 95% CI 1.04-3.25, p = 0.038), higher risk of myocardial infarction (HR 2.39, 95% CI 1.02-5.60, p = 0.045), and higher risk of cardiovascular mortality (HR 6.26; 95% CI 1.67-23.43, p = 0.006). Young patients with ACS-ACC carry a high risk of short and long-term major adverse cardiovascular events. Over the 15-year study period, we observed an increasing prevalence of this entity. This trend and its outcomes underscore the need for increased awareness and improved management strategies.

Sections du résumé

BACKGROUND
The use of cocaine as a recreational drug has increased over recent years. In this study, we aimed to analyze the prevalence, and in-hospital and long-term outcomes of acute coronary syndrome (ACS) associated with cocaine consumption (ACS-ACC).
METHODS
A prospective observational registry of young patients hospitalised with ACS from 2001 through 2015, we analysed ACS-ACC temporal trends, clinical characteristics, and major adverse cardiovascular events (MACE) during long-term follow-up.
RESULTS
There were 8153 admissions with ACS, of whom 864 patients were ≤50-years-old; 59 patients (6.8%) presented with ACS-ACC. The prevalence of patients with a history of cocaine consumption increased to maximum of 18% in 2008 with no variations thereafter (r = 0.74, p < 0.001). The ACS-ACC incidence increased over time from 5% to 9% (r = 0.25, p = 0.07). Compared to patients with ACS not associated with cocaine consumption, the ACS-ACC exhibited a higher incidence of in-hospital ventricular tachycardia (16.9% vs 4.7%, p < 0.001) and trends to in-hospital mortality (3.4% vs 1.0%, p = 0.097); during a median follow-up of 5.6 years, ACS-ACC had higher risk of MACE (HR 1.83; 95% CI 1.04-3.25, p = 0.038), higher risk of myocardial infarction (HR 2.39, 95% CI 1.02-5.60, p = 0.045), and higher risk of cardiovascular mortality (HR 6.26; 95% CI 1.67-23.43, p = 0.006).
CONCLUSION
Young patients with ACS-ACC carry a high risk of short and long-term major adverse cardiovascular events. Over the 15-year study period, we observed an increasing prevalence of this entity. This trend and its outcomes underscore the need for increased awareness and improved management strategies.

Identifiants

pubmed: 30595359
pii: S0167-5273(18)35161-1
doi: 10.1016/j.ijcard.2018.12.026
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-27

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Xavier Carrillo (X)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Research Institute Germans Trias i Pujol, Badalona, Spain; CIBERCV, Madrid, Spain. Electronic address: xcarrillo.germanstrias@gencat.cat.

Victoria Vilalta (V)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Research Institute Germans Trias i Pujol, Badalona, Spain.

German Cediel (G)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Research Institute Germans Trias i Pujol, Badalona, Spain.

Eduard Fernandez-Nofrerias (E)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Oriol Rodriguez-Leor (O)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Research Institute Germans Trias i Pujol, Badalona, Spain; CIBERCV, Madrid, Spain.

Josepa Mauri (J)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Omar Abdul Jawad-Altisent (O)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Cosme Garcia-Garcia (C)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Research Institute Germans Trias i Pujol, Badalona, Spain; CIBERCV, Madrid, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Spain.

Jordi Serra (J)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Antoni Bayes-Genis (A)

Cardiology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Research Institute Germans Trias i Pujol, Badalona, Spain; CIBERCV, Madrid, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH